Egyptian (OMX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Jul 24, 2024

Discover Egyptian Pharmaceuticals & Biotech Growth Stocks that are on the OMX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E
ج.م2.28-0.4%57.8%ج.م3.4bج.م4.41PE15.9xE29.6%2.9%

PHAR

Egyptian International Pharmaceutical Industries
ج.م39.48-0.3%50.8%ج.م5.9bج.م75.30PE4.7xE-6.7%2.5%

AXPH

Alexandria For Pharmaceuticals & Chemical Industries
ج.م210.710%52.5%ج.م1.1bn/aPE5xn/a6.2%

ADCI

Arab Drug
ج.م82.000%22.7%ج.م492.0mn/aPE7.1xn/a5.5%

NIPH

EI- Nile for Pharmaceuticals and Chemical Industries
ج.م69.780%74.5%ج.م706.5mn/aPE4.3xn/a7.2%

OCPH

October PharmaE
ج.م100.000%0%ج.م1.2bn/aPE7.6xn/a2.5%

MIPH

MINAPHARM Pharmaceuticals
ج.م190.22-0.9%-11.7%ج.م2.1bn/aPB0.5xn/a0.9%

CPCI

Kahira Pharmaceuticals & Chemical Industries
ج.م69.48-0.5%63.0%ج.م1.0bn/aPE4.4xn/a7.2%

BIOC

GlaxoSmithKlineE
ج.م28.28-1.2%-8.9%ج.م2.4bn/aPE62.7xn/a2.7%

SIPC

Sabaa International Company for Pharmaceutical and Chemical Industry
ج.م0.670%-27.8%ج.م168.3mn/aPS13.6xn/a0%

MPCI

Memphis Pharmaceuticals & Chemical Industries
ج.م88.916.2%176.2%ج.م500.1mn/aPE2.3xn/a2.2%
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.